CRS - CYTOKINE RELEASE SYNDROME
Clinical trials for CRS - CYTOKINE RELEASE SYNDROME explained in plain language.
Never miss a new study
Get alerted when new CRS - CYTOKINE RELEASE SYNDROME trials appear
Sign up with your email to follow new studies for CRS - CYTOKINE RELEASE SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study aims to tame dangerous immune reactions from cancer therapy
Disease control Recruiting nowThis study tests whether certain drugs can safely treat severe immune overreactions (CRS and HLH-like syndrome) that can happen after CAR T cell therapy. Ten adults already enrolled in a CAR T cell trial at the University of Pennsylvania will receive these rescue therapies. The g…
Matched conditions: CRS - CYTOKINE RELEASE SYNDROME
Phase: EARLY_PHASE1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated May 26, 2026 09:35 UTC
-
New study aims to predict dangerous immune reactions in blood cancer patients
Knowledge-focused Recruiting nowThis study watches 100 adults with blood cancers like lymphoma who are getting CAR T-cell or bispecific antibody therapy. Researchers track vital signs and immune markers to find early clues that a serious complication called cytokine release syndrome (CRS) may be developing. The…
Matched conditions: CRS - CYTOKINE RELEASE SYNDROME
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC